Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
06/2005
06/29/2005EP1547605A1 Adsorbents for oral administration
06/29/2005EP1547596A1 Medicinal composition and method for treating malignant tumor and utilization thereof
06/29/2005EP1545579A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
06/29/2005EP1545519A1 Combination therapy for hyperproliferative diseases
06/29/2005EP1545496A2 Nutritional supplement for adolescents
06/29/2005EP1545481A1 Combination chemotherapy compositions and methods
06/29/2005EP1545459A2 Platinum aggregates and process for producing the same
06/29/2005EP1545431A2 Methods of treating involuntary facial spasms and facial wrinkles
06/29/2005EP1117299B1 Stable glycerin iodine concentrate compositions
06/29/2005CN1633309A Method of radio-labelling biomolecules
06/29/2005CN1631377A Magnetic gastricantiacids intermediate and its preparing method
06/29/2005CN1631376A Compound medicine compatibility method of ion pair agent and vanadium compound and the application thereof
06/29/2005CN1631375A Novel compound calcium replenishing tablet
06/29/2005CN1631374A Safety compound biologic calcium formulation
06/29/2005CN1631359A Compound calcium replenishing injection
06/29/2005CN1208126C Nano-titanium dioxide photocatalyst film, preparation and its application
06/29/2005CN1208093C Pharmaceutical composition and process thereof
06/29/2005CN1208079C Medicine for treating burn scald and frostbite
06/29/2005CN1208073C Ointment for treating various skin diseases and preparation method thereof
06/29/2005CN1208069C Process for preparing liquid medicine to treat dermatopathy
06/29/2005CN1208053C Treatment of hemoglobinopathy
06/28/2005US6911438 Mixture of 2-hydroxyestrone and a substantially less amount of 17-beta estradiol
06/28/2005US6911211 Pharmaceutical and cosmetic carrier or composition for topical application
06/28/2005US6911196 Boric Acid, Zinc oxide, Calamine, Cetrimide, Olive Oil, Castor Oil, Cod liver Oil, White Petroleum base, Salicylic Acid, and Tannic Acid
06/23/2005WO2005057588A2 Granulated decontamination formulations
06/23/2005WO2005056257A2 Composition and process for coloring and preserving wood
06/23/2005WO2005056067A1 Silver coatings and methods of manufacture
06/23/2005WO2005056027A2 Solvent for biogenic active pharmaceutical ingredients
06/23/2005WO2005055984A1 Method for preparation of salt aerosol with predefined concentration
06/23/2005WO2005055963A2 Decontamination formulation with sorbent additive
06/23/2005WO2005055952A2 Synergistic anti-cancer compositions
06/23/2005WO2005055927A2 Compositions and methods for topical treatment of skin infection
06/23/2005WO2005055739A1 Edible compositions which are adapted for use by a companion animal
06/23/2005WO2005025450A3 Use of vibration with orthopedic cements
06/23/2005US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis
06/23/2005US20050137124 Agents for intravitreal administration to treat or prevent disorders of the eye
06/23/2005US20050136134 Composition for the control of pathogenic microorganisms and spores
06/23/2005US20050136131 Adding glycine to a first saturated brine, evaporating the first saturated brine and glycine to obtain:crystals comprising a high content of glycine, and mother liquor;washing the crystals with a second saturated brine to obtain:rhombic dodecahedron shaped salt comprising 0.5 to 1.0% glycine
06/23/2005US20050136130 Dietary supplements for inhibiting the progression of macular degeneration and promoting healthy vision
06/23/2005US20050136129 Administering to postsurgery and/or immobile persons; comprised of proteins, carbohydrates, fats with equivalents of arginine, ascorbic acid and alpha tocopherol
06/23/2005US20050136128 Dry powders of metal-containing compounds
06/23/2005US20050136126 Agent for reduction of scar formation by using wound alkalinization
06/23/2005US20050136125 Exposure to oxygen antagonist in vivo; organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer
06/23/2005US20050136079 Prevents or retard free radical oxidation processes in healthy skin or mucous membranes; deactivating toxins; treating microbial or viral infection; sunscreen
06/23/2005US20050136038 Organic binder having an affinity for the calcium phosphate particles, stem cells, osteogenic cells, and/or osteoprogenitor cells, and a buffer; can be injected to repair an osseous defect
06/23/2005CA2548491A1 Synergistic anti-cancer compositions
06/23/2005CA2547817A1 Composition and process for coloring and preserving wood
06/23/2005CA2547815A1 Silver coatings and methods of manufacture
06/23/2005CA2539003A1 Compositions and methods for topical treatment of skin infection
06/22/2005EP1542700A1 Method for preventing or reducing secondary fractures after hip fracture
06/22/2005EP1542653A1 A topical composition for treatment of skin disorders
06/22/2005EP1542556A2 Antimicrobial body covering articles
06/22/2005EP1272200B1 Divided dose therapies with vascular damaging activity
06/22/2005EP0932416B1 Method and potentiated composition for treating migraine
06/22/2005CN1630818A Diagnostic markers for ischemia
06/22/2005CN1630539A Multiple compartment bag assembly for dialysis fluid
06/22/2005CN1630524A 非肠道顺铂乳剂 Cisplatin parenteral emulsion
06/22/2005CN1630523A Compositions internal or relevant improvement
06/22/2005CN1630474A Tooth whitening chewing gum
06/22/2005CN1628848A Multifunctional skin lotion for painless injection and trauma clearance
06/22/2005CN1628698A Medicine for treating cholecystitis and biliary tract disease and its preparation method
06/22/2005CN1628697A Medicine for treating pertinacious porking diarrhea and its preparation method
06/22/2005CN1207215C Production method of ultrafine gold particle-dissolved water and device therefor
06/22/2005CN1207059C Chinese herbal medicine composition to be spread on sanitary napkin for female
06/22/2005CN1207051C Bone knitting bolus
06/22/2005CN1207040C Externally applied pharmaceutical composition for treating skin disease and venereal disease
06/22/2005CN1207020C Plaster for treating pain and swelling
06/22/2005CN1207013C Pox removing liquid
06/22/2005CN1207010C Liquid medicine for treating beriberi
06/22/2005CN1207008C Acne ointment and its preparing process
06/22/2005CN1207003C Minerals and crystals collecting bag for health caring of human body
06/22/2005CN1206978C Anti-caries oral compositions
06/21/2005US6908912 For controlling free-living microorganisms/biofilm growth
06/21/2005US6908909 Liquid oral compositions comprising a calcium compound and an acidulant
06/21/2005US6908636 Introducing into water with which poultry carcasses or parts are washed after slaughtering, microbiocidal amount of 1,3-dibromo-5,5-dialkylhydantoin in which one alkyl group is methyl and other contains 1 to 4 carbon atoms
06/16/2005WO2005054437A2 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitor of type i and/or type ii phosphodiesterases
06/16/2005WO2005053715A1 Agents for improving iron uptake
06/16/2005WO2005053674A1 Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
06/16/2005WO2005053620A1 Method of treating a patient’s teeth using fluoride releasing glass composition
06/16/2005WO2005053613A2 Combinations for the treatment of fungal infections
06/16/2005WO2005053605A2 Therapeutic liposomes
06/16/2005WO2005053436A1 Calcium-fortified protein-based beverage containing calcium (lactate) gluconate citrate
06/16/2005WO2005053398A1 Antimicrobial compositions comprising polymeric stabilizers
06/16/2005WO2005037188A3 Therapeutic agent for periodontal disease
06/16/2005WO2005034883A3 A method of healing skin wounds in mammals and a composition therefor
06/16/2005WO2005007117A3 Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
06/16/2005WO2004084825A3 Wound healing composition derived from low platelet concentration plasma
06/16/2005WO2004067028A8 Compound for attenuating reaction of recipient tissues to an exogenic material and method for preparing an implant/transplant for contacting tissues of the organism of said recipient
06/16/2005WO1991001624A8 Use of calcium antagonists for treating scars
06/16/2005US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic;
06/16/2005US20050129784 Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response
06/16/2005US20050129783 Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
06/16/2005US20050129782 Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions
06/16/2005US20050129781 Colonic purgative composition with soluble binding agent
06/16/2005US20050129775 Ferromagnetic particles and methods
06/16/2005US20050129771 Ophthalmic compositions containing a polysaccharide/borate gelling system
06/16/2005US20050129770 Topical applying to eye; lubricant; artificial tears
06/16/2005US20050129766 Blend of microbiocides and ethylene-vinyl alcohol copolymer on supports
06/16/2005US20050129742 Antimicrobial article with diffusion control layer
06/16/2005US20050129736 Compositions and methods for treating or preventing diseases of body passageways